Neurosense files U.S. patent application for traumatic brain injury

NRSN•2026-10-19

Neurosense Therapeutics filed a U.S. patent application for traumatic brain injury. If granted, the patent is expected to provide protection through 2047, subject to any extensions.

1. Patent application

Neurosense Therapeutics filed a U.S. patent application for traumatic brain injury. If granted, the patent is expected to provide protection through 2047, subject to any extensions.

Neurosense files U.S. patent application for traumatic brain injury

1. Patent application

Related News

Nasdaq halts trading in MNDR for volatility at 9:45 a.m.

H.B. Fuller Senior VP BAS Malik Muhammad Shahbaz reports acquisition of $24,999.99753448 in common shares

AMEX halts MYND.A

Nextdoor survey finds 78% of neighbors plan home renovations within 12 months

PPG showcases metal finishing innovations at FABTECH trade show